Luye Pharma Group Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'12 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2012 is 22.91% vs 28.32% in Jun 2011",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2012 is 46.67% vs -30.23% in Jun 2011",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'12",
        "Jun'11",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "617.00",
          "val2": "502.00",
          "chgp": "22.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "104.30",
          "val2": "84.70",
          "chgp": "23.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "12.50",
          "val2": "5.10",
          "chgp": "145.10%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "61.60",
          "val2": "42.00",
          "chgp": "46.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "128.00%",
          "val2": "136.20%",
          "chgp": "-0.82%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 4.10% vs -3.18% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 9.44% vs 17.39% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "6,841.60",
          "val2": "6,572.00",
          "chgp": "4.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,266.90",
          "val2": "2,107.80",
          "chgp": "7.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "744.60",
          "val2": "609.10",
          "chgp": "22.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "138.60",
          "val2": "-29.70",
          "chgp": "566.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "765.30",
          "val2": "699.30",
          "chgp": "9.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "198.30%",
          "val2": "190.30%",
          "chgp": "0.80%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'12 - YoY

Jun'12

Jun'11

Change(%)

Net Sales

617.00

502.00

22.91%

Operating Profit (PBDIT) excl Other Income

104.30

84.70

23.14%

Interest

12.50

5.10

145.10%

Exceptional Items

0.00

0.00

Consolidate Net Profit

61.60

42.00

46.67%

Operating Profit Margin (Excl OI)

128.00%

136.20%

-0.82%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2012 is 22.91% vs 28.32% in Jun 2011

Consolidated Net Profit

YoY Growth in quarter ended Jun 2012 is 46.67% vs -30.23% in Jun 2011

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

6,841.60

6,572.00

4.10%

Operating Profit (PBDIT) excl Other Income

2,266.90

2,107.80

7.55%

Interest

744.60

609.10

22.25%

Exceptional Items

138.60

-29.70

566.67%

Consolidate Net Profit

765.30

699.30

9.44%

Operating Profit Margin (Excl OI)

198.30%

190.30%

0.80%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 4.10% vs -3.18% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 9.44% vs 17.39% in Dec 2024

All Annual Results